Skip to main content
Clinical Trials/NCT02369770
NCT02369770
Recruiting
N/A

Sensory-Motor Rehabilitation Post Stroke

University of Maryland, Baltimore2 sites in 1 country140 target enrollmentApril 26, 2019

Overview

Phase
N/A
Intervention
stretching and active movement training
Conditions
Acute Stroke
Sponsor
University of Maryland, Baltimore
Enrollment
140
Locations
2
Primary Endpoint
Changes of Fugl-Meyer Lower Extremity (FMLE)
Status
Recruiting
Last Updated
11 days ago

Overview

Brief Summary

Early after stroke, patients often have significant motor impairment and sensory deficit. Evidence has demonstrated heightened plasticity and significant recovery in the acute phase (first months) post stroke but there has been a lack of effective and practical protocols and devices for early intensive sensorimotor therapy.This research study will conduct a randomized clinical trial of an intensive motor-sensory rehabilitation on patients with acute stroke using a wearable rehabilitation robot. The primary aims are to facilitate sensorimotor recovery, reduce ankle impairments, and improve balance and gait functions. This clinical trial will be conducted on the Study and Control groups of acute stroke survivors.

Detailed Description

The study will investigate an early intensive rehabilitation in acute stroke for motor relearning, reducing ankle impairments and improving balance and mobility/locomotion functions. The acute stroke survivor will be randomly placed into two groups. Subjects in the Study group will receive robot-aided motor relearning under real-time feedback, stretching under intelligent control, sensory stimulation, and active movement training with interactive games. Subjects in the Control group will receive passive movement in the middle ROM without intelligent stretching and active movement training without robotic guidance. For both groups, the therapeutic training will be conducted during 5 hourly sessions (including breaks/transitions between tasks) each week over about 3-week hospital stay. Both groups will also receive the standard of care in the hospital and rehabilitation service. Treatment outcome measures will be obtained through blinded assessments and evaluated before and after training involving biomechanical, neuromuscular and clinical outcome measures. Carry-over effects will be further evaluated 1 month after the treatment ends. Aim 1: To evaluate biomechanical and neuromuscular changes as defined by the passive and active range of motion (ROM), flexor-extensor muscle strength, joint stiffness, proprioception and reflex excitability, and compare these measures between the two groups. The biomechanical and neuromuscular outcome measures will be obtained through blinded assessments and evaluated before and after training using the wearable rehabilitation robot. Hypothesis 1: Robot-guided motor relearning, stretching and active movement training (Study group) will improve the biomechanical and neuromuscular outcome measures more than those of the Control group. Aim 2: To evaluate the clinical outcome measures as defined by Fugl-Meyer score (lower extremity), modified Ashworth scale, Berg balance scale, 10 meter walk test, and to compare between the Study and Control groups. Hypothesis 2: The Study group will improve the clinical outcome measures more than the Control group.

Registry
clinicaltrials.gov
Start Date
April 26, 2019
End Date
December 31, 2027
Last Updated
11 days ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Li-Qun Zhang

Principal Investigator

University of Maryland, Baltimore

Eligibility Criteria

Inclusion Criteria

  • First time unilateral acute stroke, hemorrhagic or ischemic, 24 hours after admission in hospital to 1 year post stroke.
  • Hemiplegia or hemiparesis
  • Ankle impairments

Exclusion Criteria

  • No impairment or very mild ankle impairment of ankle.
  • Unstable medical conditions that interferes with ability to training and exercise.
  • Severe cardiovascular disorders that interfere with ability to perform moderate movement exercises.
  • Cognitive impairment or aphasia with inability to follow instructions
  • Pressure ulcer, recent surgical incision or active skin disease with open wounds present below knee of treated limb
  • Severe pain in legs

Arms & Interventions

Study group

Subjects in the Study group will receive stretching and active movement training with robotic guidance and intelligent control

Intervention: stretching and active movement training

Control group

Subjects in the Control group will receive stretching and active movement training without robotic guidance.

Intervention: stretching and active movement training

Outcomes

Primary Outcomes

Changes of Fugl-Meyer Lower Extremity (FMLE)

Time Frame: At the beginning and end of 3-week training, and 1 month after the treatment ends

The assessment is a measure of lower extremity (LE) motor and sensory impairments.

Secondary Outcomes

  • Changes of ankle stiffness(At the beginning and end of 3-week training, and 1 month after the treatment ends)
  • Changes of passive range of motion (PROM)(At the beginning and end of 3-week training, and 1 month after the treatment ends)
  • Changes of active range of motion (AROM)(At the beginning and end of 3-week training, and 1 month after the treatment ends)
  • Changes of Modified Ashworth Scale (MAS)(At the beginning and end of 3-week training, and 1 month after the treatment ends)
  • Changes of ankle strength(At the beginning and end of 3-week training, and 1 month after the treatment ends)
  • Changes of Berg Balance Scale(At the beginning and end of 3-week training, and 1 month after the treatment ends)
  • Changes of 10 meter Walk Test(At the beginning and end of 3-week training, and 1 month after the treatment ends)

Study Sites (2)

Loading locations...

Similar Trials